Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2017 / Articles / Jan / Parents Pass Placebos
Discovery & Development Clinical Trials

Parents Pass Placebos

Is it ethical to use placebo controls in pediatric clinical trials? Most parents say, “yes”

By James Strachan 01/19/2017 1 min read

Share

The ethics around placebos have been discussed for some time in the medical community, but it’s an even more hotly debated subject when it comes to clinical trials involving children, despite evidence suggesting that placebo effects in pediatrics are significant. Clearly, children require special consideration and a trial can’t go ahead without parental consent, so it’s important to understand what parents think. Until recently, data has been lacking but now researchers from Harvard Medical School have conducted a survey to assess parental attitudes regarding placebo usage in pediatric, randomized controlled trials and clinical care (1). “Our aim was to further understand the obstacles related to children enrolment in a placebo randomized controlled trial and to understand the feasibility of clinical opportunities, such as placebo therapy, which can maintain the therapeutic benefits and decrease the use of medication with potential side effects,” said Vanda Rocha Faria, lead author of the study and Research Fellow in Anesthesia at Boston’s Children’s Hospital.

The researchers found that the majority of surveyed parents considered the use of placebos acceptable in both pediatric care (86 percent) and pediatric trials (91.5 percent), while only 5.7 percent of parents reported the use of placebos in children as unacceptable. Respondents’ judgment and acceptance were influenced by the doctors’ certainty about the therapeutic benefits of placebo treatment, the pediatric conditions for placebo usage (mostly psychological), transparency, safety, and purity of placebos. Interestingly, the researchers also found that more than two-thirds of parents would rather have their child enrol in a clinical study to test the effectiveness of a new drug against a placebo without pharmacologic side effects than in a study testing the new drug against an already existing drug with possible pharmacologic side effects. Most parents also indicated that they would like to be informed about clinical trials results and, if results suggest that certain drugs do not work better than placebo, do not believe it acceptable for a doctor to prescribe those drugs to children.

“In out study, we found that parents seem to be quite positive towards placebo use,” says Rocha Faria. “However, if deception is involved, then their attitudes change.” Rocha Faria also pointed out that a number of parents spontaneously left positive comments at the end of the survey. “Some said they would like to read more on the topic, others that they would like to see our recommendations implemented in clinical practice... I think it shows there’s a genuine interest in the topic.”

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. V Faria, “Parental attitudes about placebo use in children”, J Pediatr [Epub ahead of print] (2016). PMID: 27863847.

About the Author(s)

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

More Articles by James Strachan

False

Advertisement

Recommended

False

Related Content

The (Un)fairer Sex?
Clinical Trials
The (Un)fairer Sex?

November 6, 2014

0 min read

Our understanding of the differences in male and female biology is constantly growing – but can we translate that knowledge into better healthcare for all?

Sex Matters
Clinical Trials
Sex Matters

November 6, 2014

0 min read

New NIH policies aim to correct the sex bias in preclinical research

Asking the Right Questions in R&D
Clinical Trials Contract Development Services Trends & Forecasts
Asking the Right Questions in R&D

March 6, 2025

3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

AI, Big Data, and Digital Disruption
Digital Technologies Clinical Trials
AI, Big Data, and Digital Disruption

March 31, 2025

7 min read

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.